P47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO

Nature Communications

Volumn 3, Issue , 2012, Pages

  Shibata, Yuri ^a   Oyama, Masaaki ^a   Kozuka Hata, Hiroko ^a   Han, Xiao ^a   Tanaka, Yuetsu ^b   Gohda, Jin ^a   Inoue, Jun Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE GAMMA; INTERLEUKIN 1; PROTEIN P47; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME REGULATION; LYSOSOME; PROTEIN FUNCTION;

ADENOSINE TRIPHOSPHATASES; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HELA CELLS; HUMANS; I-KAPPA B KINASE; IMMUNOPRECIPITATION; JURKAT CELLS; LYSOSOMES; NF-KAPPA B; NUCLEAR PROTEINS; POLYUBIQUITIN; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; SF9 CELLS; SOLUBLE N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEINS;

EID: 84867032420     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2068     Document Type: Article

References (60)

1. Iwai, K. & Tokunaga, F. Linear polyubiquitination: a new regulator of NF-κB activation. EMBO Rep. 10, 706-713 (2009).
2. Gautheron, J. & Courtois, G. 'Without Ub I am nothing': NEMO as a multifunctional player in ubiquitin-mediated control of NF-κB activation. Cell. Mol. Life Sci. 67, 3101-3113 (2010).
3. Liu, S. & Chen, Z. J. Expanding role of ubiquitination in NF-κB signaling. Cell Res. 21, 6-21 (2011).
4. Hayden, M. S. & Ghosh, S. Shared principles in NF-κB signaling. Cell 132, 344-362 (2008).
5. Sun, S. C. Controlling the fate of NIK: a central stage in noncanonical NF-κB signaling. Sci. Signal. 3, pe18 (2010).
6. Xia, Z. P. et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114-119 (2009).
7. Lamothe, B. et al. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation. J. Biol. Chem. 282, 4102-4112 (2007). (Pubitemid 47084488)
8. Yamazaki, K. et al. Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling. Sci. Signal. 2, ra66 (2009).
9. Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
10. Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004). (Pubitemid 39141781)
11. Laplantine, E. et al. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 28, 2885-2895 (2009).
12. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001). (Pubitemid 32694385)
13. Mahoney, D. J. et al. Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl Acad. Sci. USA 105, 11778-11783 (2008).
14. Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689-700 (2008). (Pubitemid 351818251)
15. Xu, M., Skaug, B., Zeng, W. & Chen, Z. J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36, 302-314 (2009).
16. Ni, C. Y. et al. Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo. J. Immunol. 180, 7107-7111 (2008).
17. Sebban-Benin, H. et al. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum. Mol. Genet. 16, 2805-2815 (2007).
18. Abbott, D. W., Wilkins, A., Asara, J. M. & Cantley, L. C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14, 2217-2227 (2004). (Pubitemid 40033358)
19. Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123-132 (2009).
20. Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 (2011).
21. Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641 (2011).
22. Tokunaga, F. et al. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636 (2011).
23. Yamamoto, Y. & Gaynor, R. B. Role of the NF-κB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 1, 287-296 (2001). (Pubitemid 33773312)
24. Tak, P. P. & Firestein, G. S. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11 (2001). (Pubitemid 32047405)
25. Sun, S. C. CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes. Cell Death Differ. 17, 25-34 (2010).
26. Inoue, J., Gohda, J., Akiyama, T. & Semba, K. NF-κB activation in development and progression of cancer. Cancer Sci 98, 268-274 (2007). (Pubitemid 46195594)
27. Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699 (2004).
28. Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801-805 (2003). (Pubitemid 37021712)
29. Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424, 793-796 (2003). (Pubitemid 37021710)
30. Komander, D. et al. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 10, 466-473 (2009).
31. Malynn, B. A. & Ma, A. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme. J. Exp. Med. 206, 977-980 (2009).
32. Kondo, H. et al. p47 is a cofactor for p97-mediated membrane fusion. Nature 388, 75-78 (1997). (Pubitemid 27283891)
33. Patel, S. & Latterich, M. The AAA team: related ATPases with diverse functions. Trends Cell Biol. 8, 65-71 (1998). (Pubitemid 28056813)
34. Roy, L. et al. Role of p97 and syntaxin 5 in the assembly of transitional endoplasmic reticulum. Mol. Biol. Cell 11, 2529-2542 (2000). (Pubitemid 30645024)
35. Hetzer, M. et al. Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly. Nat. Cell Biol. 3, 1086-1091 (2001). (Pubitemid 33130459)
36. Shibata, Y., Tanaka, Y., Gohda, J. & Inoue, J. Activation of the IκB kinase complex by HTLV-1 Tax requires cytosolic factors involved in Tax-induced polyubiquitination. J. Biochem. 150, 679-686 (2011).
37. Meyer, H. H., Wang, Y. & Warren, G. Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J. 21, 5645-5652 (2002). (Pubitemid 35315264)
38. Schuberth, C., Richly, H., Rumpf, S. & Buchberger, A. Shp1 and Ubx2 are adaptors of Cdc48 involved in ubiquitin-dependent protein degradation. EMBO Rep. 5, 818-824 (2004). (Pubitemid 39199173)
39. Yuan, X. et al. Structure, dynamics and interactions of p47, a major adaptor of the AAA ATPase, p97. EMBO J. 23, 1463-1473 (2004). (Pubitemid 38579507)
40. Hartmann-Petersen, R. et al. The Ubx2 and Ubx3 cofactors direct Cdc48 activity to proteolytic and nonproteolytic ubiquitin-dependent processes. Curr. Biol. 14, 824-828 (2004). (Pubitemid 38583720)
41. Wojcik, C., Yano, M. & DeMartino, G. N. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J. Cell Sci. 117, 281-292 (2004). (Pubitemid 38128906)
42. Uchiyama, K. et al. The localization and phosphorylation of p47 are important for Golgi disassembly-assembly during the cell cycle. J. Cell Biol. 161, 1067-1079 (2003). (Pubitemid 36870169)
43. Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7, 962-970 (2006). (Pubitemid 44263910)
44. Zhong, H., Voll, R. E. & Ghosh, S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1, 661-671 (1998). (Pubitemid 128379244)
45. Hofmann, K. & Bucher, P. The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem. Sci. 21, 172-173 (1996). (Pubitemid 126335285)
46. Buchberger, A., Howard, M. J., Proctor, M. & Bycroft, M. The UBX domain: a widespread ubiquitin-like module. J. Mol. Biol. 307, 17-24 (2001). (Pubitemid 33029961)
47. Kaneko, Y., Tamura, K., Totsukawa, G. & Kondo, H. Isolation of a point-mutated p47 lacking binding affinity to p97ATPase. FEBS Lett. 584, 3873-3877 (2010).
48. Wojcik, C. et al. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol. Biol. Cell 17, 4606-4618 (2006). (Pubitemid 44665732)
49. Kang, R. S. et al. Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding. Cell 113, 621-630 (2003). (Pubitemid 36694187)
50. Tang, E. D., Wang, C. Y., Xiong, Y. & Guan, K. L. A role for NF-κB essential modifier/IκB kinase-γ (NEMO/IKKγ) ubiquitination in the activation of the IκB kinase complex by tumor necrosis factor-α. J. Biol. Chem. 278, 37297-37305 (2003).
51. Rhodes, D. R. et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166-180 (2007).
52. Yamagishi, M. et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers. Cancer Cell 21, 121-135 (2012).
53. Watanabe, M. et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 106, 2462-2471 (2005). (Pubitemid 41510821)
54. Krick, R. et al. Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8. J. Cell Biol. 190, 965-973 (2010).
55. Kirkin, V. et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol. Cell 33, 505-516 (2009).
56. Komatsu, M. et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131, 1149-1163 (2007). (Pubitemid 350235021)
57. Skaug, B. et al. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol. Cell 44, 559-571 (2011).
58. Lee, E. G. et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289, 2350-2354 (2000).
59. Shembade, N., Ma, A. & Harhaj, E. W. Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135-1139 (2010).
60. Reiley, W. W. et al. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J. Exp. Med. 204, 1475-1485 (2007). (Pubitemid 46919884)